Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.82	21.17	27.07
Graham Fair Price	-31.18	9.21	13.39
PEG	-599.55	-0.95	-0.14
Price/Book	-4.98	0.59	0.62
Price/Cash Flow	-96.44	35.17	986.90
Prices/Earnings	102.97	51.72	25.48
Price/Sales	-6.26	3.89	4.15
Price/FCF	-96.44	35.17	986.90
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	20.46	0.13	0.10
Operating Margin	-18.32	0.03	0.03
ROA	-53.05	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-53.18
ROIC	< 0.005	< 0.005	-18.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.14	0.17	-20.54
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.80	-0.17	-78.57
EPS QOQ	1.88	-0.55	-70.99
FCF QOQ	-0.94	25.68	2636.50
Revenue QOQ	0.11	0.01	-86.42
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.99	73.00	1.40
Days Sales Outstanding (DSO)	76.22	65.71	-13.79
Inventory Turnover	1.25	1.23	-1.38
Debt/Capitalization	0.07	0.08	12.53
Quick Ratio	1.40	1.41	0.37
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	36.13	36.34	0.57
Cash	4.13	3.99	-3.43
Capex	-0.89	-0.64	27.87
Free Cash Flow	0.02	0.61	2581.69
Revenue	5.41	5.52	1.95
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.14	2.28	6.22
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.06	0.77	-62.48
Naive Interpretation	Member

06 - Financial Health · Bad

Rating